BALTIC18 5th Baltic Meeting in conjunction with the EAU May 2018, Riga, Latvia Programme

Transcription

1 BALTIC18 5th Baltic Meeting in conjunction with the EAU May 2018, Riga, Latvia Programme

2 General Information Abstracts The presented abstracts of the 5th Baltic meeting are going to be published online by Elsevier as an official supplement of European Urology. These e-abstracts will be online as of 1 July 2018 at The abstracts will also be online at The abstracts are documented in an international online journal and can be cited, providing proof of the academic productivity of the regions. Accreditation The 5th Baltic Meeting in conjunction with the EAU is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), The 5th Baltic Meeting in conjunction with the EAU is designated for a maximum of 11 hours of European external CME credits. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. Certificate of attendance Delegates who have attended the meeting can print their certificate of attendance online through using the barcode on the badge. This option is available as of Wednesday, 30 May Exhibition The local organising committee has invited pharmaceutical companies, manufacturers of technical equipment and software as well as publishers of scientific books to exhibit their products at the exhibition organised at the meeting venue. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits. Information on the process to convert EACCME credit to AMA credit can be found at internationalcme. 2 5th Baltic meeting in conjunction with the EAU

3 Programme Friday, 25 May Welcome P. Vaganovs, Riga (LV) M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) A. Strotsky, Minsk (BY) C.R. Chapple, Sheffield (GB) J.O.R. Sonksen, Herlev (DK) EAU Lecture Where are we in male infertility in 2018? J.O.R. Sonksen, Herlev (DK) Session 1 Advances in imaging radiotherapy on prostate cancer Chairs: M. Kivi, Tallinn (EE) E. Vjaters, Riga (LV) Evaluation of multiparametric prostate MRI M. Žarkovski, Tartu (EE) The role of robotic radiosurgery in treatment of solitary and oligometastatic relapses of prostate cancer M. Mezeckis, Sigulda (LV) Low-dose rate and high-dose rate brachytherapy in prostate cancer R.A. Lenkaityte, Vilnius (LT) Use of PSMA PET-CT in biochemical relapse of prostate cancer M. Kalnina, Riga (LV) Coffee break Young Urologists Competition Chairs: T. Murtola, Kangasala (FI) J. Vasquez, Copenhagen (DK) Judges: C.R. Chapple, Sheffield (GB) M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) J.O.R. Sonksen, Herlev (DK) A. Strotsky, Minsk (BY) P. Vaganovs, Riga (LV) Prostate Cancer Screening: Current status and future perspectives S. Semenov, Minsk (BY) The role of gene polymorphisms in female urinary incontinence P. Aniulis, Kaunas (LT) May

4 Programme Friday, 25 May Multidisciplinary management of blunt kidney trauma K. Miculis, Riga (LV) Upper Tract Urothelial Carcinoma: Is it possible to save the kidney? T. Põdramägi, Tartu (EE) Industry sponsored session See programme page Lunch and poster viewing Poster session 1: Prostate cancer - screening, detection and surveillance Room: Beta 1 Chairs: F. Jankevicius, Vilnius (LT) J.O.R. Sonksen, Herlev (DK) Poster session 2: Voiding dysfunction, andrology and miscellaneous Room: Beta 2 Chairs: C.R. Chapple, Sheffield (GB) A. Strotsky, Minsk (BY) Session 2 Urinary tract infections Chairs: C.R. Chapple, Sheffield (GB) J. Kahu, Tartu (EE) Possibilities and challenges in treatment of recurrent UTI D. Nitkin, Minsk (BY) Influences on microbiome - quo vadis? A. Gessner, Regensburg (DE) Perioperative antibacterial prophylaxis U. Dumpis, Riga (LV) Discussion Coffee break and poster viewing Poster session 3: Renal cancer and treatment of prostate cancer Room: Beta 1 Chairs: M. Jievaltas, Vilnius (LT) T. Murtola, Kangasala (FI) Poster session 4: Adrenals and stones Room: Beta 2 Chairs: P. Vaganovs, Riga (LV) J.L. Vasquez, Copenhagen (DK) 4 5th Baltic meeting in conjunction with the EAU

5 Programme Friday, 25 May 2018 ESU/ ESUT Hands-on Training in laparoscopy Course Coordinator: P. Macek, Prague (CZ) Format: Room: Introduction by course coordinator (5 minutes) Hands-on-training at different models (80 minutes) Questions and answers, tips and tricks (5 minutes) Gamma Course 1 Chair: P. Macek, Prague (CZ) Tutors: C.S. Biyani, Leeds (GB) P. Macek, Prague (CZ) T. Muul, Tartu (EE) Course 2 Chair: P. Macek, Prague (CZ) Tutors: C.S. Biyani, Leeds (GB) P. Bosas, Kaunas (LT) P. Macek, Prague (CZ) Course 1: Case discussions, Tips & Tricks and Experience exchange Tutors: C.S. Biyani, Leeds (GB) P. Macek, Prague (CZ) This course will focus on the technical aspects of interesting clinical cases. Two expert surgeons discuss 1-2 prepared cases, each that show a difficult situation that occurs during surgery (e.g. management of bleeding of the renal pedicle during lap. Nephrectomy) and how to manage this situation. The cases are prepared by the tutors of the course and discussed with the participants of the course in an interactive way. Furthermore special tips & tricks are shown and/or discussed by the tutors. This leads to an experience exchange that is beneficial for every participant of the course. Aims and objectives Laparoscopic procedures are continuously evolving in urology based on the increasing expertise of urologic surgeons. This includes ablative procedures, such as radical nephrectomy as well as reconstructive techniques, such as pyeloplasty. Some advanced procedures (i.e. radical prostatectomy, radical cystectomy) have both, ablative and reconstructive steps. Since the number of centres with laparoscopic expertise is still limited in Europe, laparoscopic training programmes have become very important. Hands-on training courses at the pelvi-trainer represent one of the ain steps of such courses. Finally, all remaining questions can be answered and discussed with all tutors including the demonstration of tips and tricks May

6 Programme Saturday, 26 May State-of-the-art lecture Prostate cancer Chairs: F. Jankevicius, Vilnius (LT) J.O.R. Sonksen, Herlev (DK) Update on prostate cancer N. Mottet, Saint-Étienne (FR) Discussion Coffee break Industry sponsored session See programme page ESU Course Bladder cancer Chair: J. Palou, Barcelona (ES) European School of Urology: A unique possibility for urological education J. Palou, Barcelona (ES) EAU Guidelines recommendations on bladder cancer J. Palou, Barcelona (ES) Urinary markers in bladder cancer: The future? E. Xylinas, Paris (FR) TURBT, Re-TURBT, En bloc resection: Where are we? J. Palou, Barcelona (ES) Let s improve the management of patients in radical cystectomy E. Xylinas, Paris (FR) Chemotherapy, Immunotherapy or what in metastatic bladder cancer? J. Palou, Barcelona (ES) Interactive case discussion ESU faculty M. Meniss, Riga (LV) M. Mikkal, Tartu (EE) Lunch and poster viewing 6 5th Baltic meeting in conjunction with the EAU

7 Programme Saturday, 26 May Poster session 5: Urothelial tumours and BPO Room: Beta 1 Chairs: A. Minich, Minsk (BY) TBC Poster session 6: Infections and paediatrics Room: Beta 2 Chairs: V. Lietuvietis, Riga (LV) TBC Session 3 Video session Chairs: M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) D possibilities in laparoscopic surgery E. Vjaters, Riga (LV) Laser en bloc resection of bladder tumour D. Tarend, Minsk (BY) Laparoscopic surgery: transvaginal NOTES-assisted laparoscopic nephroureterectomy P. Bosas, Vilnius (LT) Laparoscopic removal of large adrenal gland tumour R. Ots, Tartu (EE) Awards for Best Poster Presentation and Young Urologist Competition P. Vaganovs, Riga (LV) Closing remarks and farewell P. Vaganovs, Riga (LV) M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) A. Strotsky, Minsk (BY) May

8 Programme Saturday, 26 May 2018 ESU/ ESUT Hands-on training in Ureterorenoscopy Course Coordinator: A. Ploumidis, Athens (GR) Format: Room: Introduction by course coordinator (15 minutes) Hands-on-training at different models (80 minutes) Questions and answers, tips and tricks (25 minutes) Gamma Course 1 Chair: A. Ploumidis, Athens (GR) Tutors: C.S. Biyani, Leeds (GB) I. Geldners, Riga (LV) A. Ploumidis, Athens (GR) Course 2 Chair: A. Ploumidis, Athens (GR) Tutors: C.S. Biyani, Leeds (GB) R. Ots, Tartu (EE) A. Ploumidis, Athens (GR) Course 2: Case discussions, Tips & Tricks and Experience exchange Tutors: C.S. Biyani, Leeds (GB) A. Ploumidis, Athens (GR) This course will focus on the technical aspects of interesting clinical cases. Two expert surgeons discuss 1-2 prepared cases, each that show a difficult situation that occurs during surgery (e.g. management of bleeding of the renal pedicle during lap. Nephrectomy) and how to manage this situation. The cases are prepared by the tutors of the course and discussed with the participants of the course in an interactive way. Furthermore special tips & tricks are shown and/or discussed by the tutors. This leads to an experience exchange that is beneficial for every participant of the course. Aims and objectives The European Society of Uro-Technology (ESUT) and the EAU Section of Urolithiasis (EULIS) offer an intensive hands-on training course with different models focussing on the endoscopic management of urolithiasis. The delegates will be taken through a sequential programme of Ureterorenoscopy using normal endoscopic instruments in different models. The use of various guide-wires, baskets and intracorporeal lithotripters will be demonstrated. The ESUT and the EULIS faculty consist of experienced surgeons in the field of Ureterorenoscopy. A video demonstrating the different steps and tasks of the procedures will be presented and afterwards the delegates will be instructed according to their level of experience in small teams at the models. Finally, all remaining questions can be answered and discussed with all tutors including the demonstration of tips and tricks. 8 5th Baltic meeting in conjunction with the EAU

9 Poster session 1 Friday, 25 May Prostate cancer - screening, detection and surveillance Chairs: F. Jankevicius, Vilnius (LT) J.O.R. Sonksen, Herlev (DK) Beta Room 1 1 Multiple cancers among prostate cancer patients diagnosed in Estonia Kase M., Ojamaa K., Vardja M., Kase S., Zahharova I., Jaal J., Jaal J. (Tallinn,Tartu, Estonia; Riga, Latvia) 2 Association between ABO blood groups and aggressiveness of prostate cancer Bhuvanagiri A.K., Kannan S, Williams W.S.M, Gundupalli D., Fegredo D., Hassan U., Allen B., Robinson B., Arshad S., Nadeem T., Edge E., Tivey A., Thangavelu M., Ahiaku E.K, Alexandrou K. (Bangor, United Kingdom) 3 Does PSA-based population screening increase suicide risk in prostate cancer patients? National experience from Lithuania early detection programme Patasius A., Kaceniene A., Ulys A., Smailyte G. (Vilnius, Lithuania) 4 Divergent Maspin expression in benign and malignant basal cell lesions in the prostate Otzetov A.G., T. Sitaram R., Mallikajuna P., Wanders A. (Umeå, Sweden) 5 Association of body mass index, PSA, prostate volume and prostate cancer Bhuvanagiri A.K., Kannan S., Gundupalli D., Fegredo D., Nadeem T., Tivey A., Edge E., Allen B., Robinson B., Thangavelu M., Ahiaku E.K, Alexandrou K. (Bangor, United Kingdom) 6 Diagnostic accuracy of [-2]proPSA, %p2psa and Prostate Health Index for prostate cancer detection Barisiene M., Stanciute D., Bakavicius A., Jurkeviciene J., Zelvys A., Ulys A., Jankevicius F. (Vilnius, Lithuania) 7 What should be the PSA threshold value in patients with PSA elevation without digital rectal examination findings? 2,5 or 4 ng/ml? Ediz C., Yilmaz Ö., Koksal O., Akan S., Ates F., Cakmak S., Temel M.C., Hayit H., Sariogullari U. (Istanbul, Turkey) 8 Early detection of prostate cancer in men aged with PSA level ng/ml Semenov S., Krasny S., Minich A. (Minsk, Belarus) 9 The diagnostic value of PSA density in predicting prostate biopsy outcomes Maris N., Kotsar A., Žarkovski M., Värk P., Punab M. (Tartu, Estonia) 10 Pathological correlation between needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer G1 Sperga G., Jakubovskis M., Sperga M., Redmanis L., Lietuvietis V. (Riga, Latvia) 11 Repeated 24-core systematic and targeted biopsy in detection of clinically significant prostate cancer Karman A.V., Shimanets S.V., Minich A.A., Rolevich A.I., Karman T.A., Krasny S.A. (Minsk, Belarus) 12 Multiparametric MRI targeted and transrectal ultrasound guided transperineal prostate biopsy in men with previous negative prostate biopsy Kivi M., Nelzin D., Kõdar K., Semjonov E. (Tallinn, Estonia) 13 PET CT [18F] - labelled choline imaging in primary assessment of prostate cancer: Is it helpful in local staging? Witek M., Klonowski P., Jaskulski J., Orlowski P., Obarzanowski M. (Kielce, Poland) 14 mpmagnetic Resonance Imaging accuracy in the detection of localized prostate cancer Narcisko V.F, Baumanis E., Lietuvietis V., Strazdina A. (Riga, Latvia) 15 Epigenetic markers to overcome limitations in prostate cancer diagnostics Bakavicius A., Daniunaite K., Jarmalaite S., Jankevicius F. (Vilnius, Lithuania) 16 Evaluation of patients with greater risk of prostate cancer progression in active surveillance after second biopsy Mickevicius L., Mickevicius R., Jievaltas M. (Kaunas, Lithuania) 17 Low risk prostate cancer - active surveillance outcomes Ediz C., Yilmaz Ö., Ates F., Akan S., Sariogullari U., Cakmak S., Temel M.C., Hayit H. (Istanbul, Turkey) May

10 Poster session 2 Friday, 25 May Voiding dysfunction, andrology and miscellaneous Chairs: C.R. Chapple, Sheffield (GB) A. Strotsky, Minsk (BY) Beta Room 2 18 Does inguinal hernia repair affect uroflowmetric parameters? A prospective controlled clinical trial Unal Y., Kilinc M.F. (Ankara, Turkey) 19 The influence of specific urinary incontinence type on the quality of life of incontinent women Volotovska J., Dr. Pilsetniece Z., Prof. Vjaters E. (Riga, Latvia) 20 Patient history, physical and urodynamic data role in diagnostic of specific type of urinary incontinence in female Pilsetniece Z., Vjaters E. (Riga, Latvia) 21 Efficacy of suburethral sling for the treatment of female stress urinary incontinence Chaker K., Sellami A., Ben Chehida M.A., Ben Rhouma S., Nouira Y. (Tunis, Tunisia) 22 Effectiveness of different postoperative training programs on pelvic floor muscles strengthening and reducing of urinary incontinence in men after radical prostatectomy: Results of randomized controlled clinical trial Milonas D., Siupsinskas L., Zachovajevas P., Zachovajieviene B. (Kaunas, Lithuania) 23 Tamsulosin can improve lower urinary tract symptoms in patients under active surveillance due to low risk prostate cancer Dalkilic A., Bayar G., Kilinc M.F., Yavuz A., Tanriverdi O., Horasanli K. (Istanbul,Ankara,Hatay, Turkey) 24 Treatment of dysuric disorders in patients with urinary bladder leukoplakia Rahuzin A., Strotsky A., Obrazkov K. (Minsk, Belarus) 25 The effect of hyperbaric oxygen therapy on erectile functions: A prospective clinical study Sahin M.O., Sen V., Eser E., Koc E., Gumus U., Karakuzu C., Ucer O. (Manisa,Izmir, Turkey) 26 Ultrasound examination internal genital artery transperineal access when arteriogenic erectile dysfunction Povelitsa E. (Gomel, Belarus) 27 Self-treatment methods of patients diagnosed with premature ejaculation before admission Cimen S. (Malatya, Turkey) 28 Etiological factors and management of priapism Chaker K., Sellami A., Ouanes Y., Bibi M., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia) 29 Approach to managing penile fractures at a secondary state hospital Cimen S. (Malatya, Turkey) 30 Which factors affect the success of iatrogenic obstetric vesical fistulas? Kati B., Ciftci H., Pelit E.S., Yagmur I., Ordek E. (Sanliurfa, Turkey) 31 Prognostic factors of laparoscopic Anderson-Hynes pyeloplasty in treatment of ureteropelvic junction obstruction: A pilot study Cekauskas A., Jakubauskas M., Bielinis A., Vajauskas D., Zelvys A. (Vilnius, Lithuania) 32 Intraurethral erythropoietin to prevent fibrosis and improve urethral healing: An experimental study in a rat model Kilinc M.F., Doluoglu O.G., Eser E.P., Yildiz Y., Yazar V.M., Ayyildiz A., Hucumenoglu S. (Ankara, Turkey) 33 Ureteral stricture relapse risk factors after endoureterotomy Chernysheva D., Popov S.V., Orlov I.N., Vyazovtsev P.V. (Saint-Petersburg, Russia) V1 Laparoscopic pyeloplasty combined with flexible nephroscopy Cerskute M., Cekauskas A., Januskevicius T., Tyla R., Zelvys A. (Vilnius, Lithuania) 10 5th Baltic meeting in conjunction with the EAU

11 Poster session 3 Friday, 25 May Renal cancer and treatment of prostate cancer Chairs: M. Jievaltas, Kauno Rajonas (LT) T. Murtola, Kangasala (FI) Beta Room 1 34 Renal cancer incidence, mortality and survival trends in Estonia, Sepp T., Kotsar A., Lang K., Innos K. (Tartu, Tartu,Tallinn, Estonia) 35 DNA methylation profile of cear cell renal carcinoma Kubiliute R., Žalimas A., Ulys A., Jankevicius F., Jarmalaite S. (Vilnius, Lithuania) 36 Tumors of native kidneys in dialysed and in renal transplant patients Cekas K., Ramonas H. (Vilnius, Lithuania) 37 Role of nephrometric scores in the prediction of warm ischemia time and the renal function outcomes in patients who underwent nephron-sparing surgery for renal cancer Chaker K., Sellami A., Ouanes Y., Bibi M., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia) 38 Predictors of renal parenchymal volume loss after partial nephrectomy Atalay H.A., Özbir S. (Istanbul, Turkey) 39 Surgery for metastases of renal cell carcinoma: Outcome of treatments and external assessment of Leuven-Udine prognostic groups Erkkilä K., Visapää H., Kilpeläinen T., Taari K., Järvinen R., Tornberg S., Nisen H., Järvinen P. (Helsinki, Finland) 40 Retroperitoneal and transperitoneal laparoscopic cryoablation of small renal tumours - follow up study Kailasa A.K., Rogers M., Khan I. (Scunthorpe, United Kingdom) 41 Impact of the metabolic syndrome on the renal function after partial nephrectomy for non metastatic localized renal cell carcinoma Chaker K., Ben Rhouma S., Sellami A., Ouanes Y., Bibi M., Ben Chehida M.A., Abid K., Nouira Y. (Tunis, Tunisia) 42 Renal function outcomes after partial nephrectomy and radical nephrectomy for small renal cancer: A comparative study Chaker K., Sellami A., Ouanes Y., Bibi M., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia) 43 Overall survival in patients underwent open partial nephrectomy in a solitary kidney Suslov L., Sukonko O., Polyakov S., Krasny S., Mirilenko L. (Minsk, Belarus) 44 Quality of life after medical versus surgical castration for locally advanced or metastatic prostate cancer Chaker K., Sellami A., Ouanes Y., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia) 45 Long-term outcome of localized prostate cancer treated with brachytherapy Vaiciunas K., Babakinas J., Jokubonis K., Jarusevicius L., Inciura A., Juozaityte E., Jievaltas M. (Kaunas, Lithuania) 46 4 years outcome in 143 patients receiving low-dose I125 brachytherapy Purvaneckas J., Makevicius J., Rimas A., Sniureviciute M. (Vilnius, Lithuania) 47 Influence of number of core with adenocarcinoma on Gleason score upgrade in patients undergoing radical prostatectomy Ediz C., Akan S., Cakmak S., Ates F., Yilmaz O., Temel M.C., Koksal O., Hayit H., Sariogullari U. (Istanbul, Turkey) 48 Effectiveness of salvage pelvic surgery for clinically recurrent prostate cancer after initial curative treatment: First experience of single tertiary center Domarkas A., Auskalnis S., Jievaltas M., Milonas D. (Kaunas, Lithuania) 49 Do the pelvic irradiation and adjuvant androgen-deprivation therapy improve efficacy of salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy? Polyakov S., Semenov S., Demeshko P., Krasny S. (Minsk, Belarus) 50 Metastasis-free and cancer-specific survival after salvage radiotherapy in patients with biochemical recurrence treated with radical prostatectomy Polyakov S., Krasny S., Demeshko P., Semenov S., Minich A. (Minsk, Belarus) 51 Blood-circulating androgen receptor variants as markers for progression and response to treatment in prostate cancer patients Stuopelyte K., Sestokaite A., Haflidadottir B.S., Visakorpi T., Ulys A., Jankevicius F., Jarmalaite S. (Vilnius, Lithuania; Tampere, Finland) 52 The importance of immediate prostate specific antigen value after radical prostatectomy on prediction of clinical progression in lymph node positive patients Astrauskas M., Cepas G., Jievaltas M., Milonas D. (Kaunas, Lithuania) 53 Prognostic significance of time until biochemical recurrence on clinical progression in surgically treated high-risk prostate cancer patients Venclovas Z., Auskalnis S., Jievaltas M., Milonas D. (Kaunas, Lithuania) 54 68Ga-PSMA ligand PET/CT in patients with biochemical recurrence after prostate cancer treatment - initial data Freimanis A., Lietuvietis V., Vjaters E., Roznere L., Zemniece L., Kalnina M., Tirane M., Radzina M. (Riga, Latvia) 55 The effect of lymphadenectomy extent on early postoperative undetectable PSA rate among prostate cancer pt3b R0 patients at West-Tallinn Central Hospital Okas R., Alas I. (Tallinn, Estonia) May

12 Poster session 4 Friday, 25 May Adrenals and stones Chairs: P. Vaganovs, Riga (LV) J.L. Vásquez, Copenhagen (DK) Beta Room 2 56 Adrenal ganglioneuroma: A case report Kivi M., Ahlberg A., Kalju K., Kõdar K. (Tallinn, Estonia) V2 Laparoscopic left adrenalectomy. Adrenal ganglioneuroma Kivi M., Ahlberg A., Põdramägi T., Dmitrijeva N., Levin D. (Tallinn, Estonia) 57 Analysis of the impact on complications of remaining in the surgical waiting list for endoscopic treatment of ureteral stones Purvaneckas J., Želvys A. (Vilnius, Lithuania) 58 Association between haematuria and urinary tract calculi Bhuvanagiri A.K., Kannan S., Gundupalli D., Fegredo D., Nadeem T., Allen B., Robinson B., Edge E., Tivey A., William S.M.W., Thangavelu M., Ahiaku E.K, Alexandrou K. (Bangor, United Kingdom) 59 White cell count, C-reactive protein and serum creatinine as indicators for stent insertions in urinary tract stones Kannan S., Bhuvanagiri A., Gundupalli D., Fegredo D., Nadeem T., Allen B., Robinson B., Edge E., Tivey A., Thangavelu M., Ahiaku E., Alexandrou K. (Bangor, United Kingdom) 60 A new approach to the dietary stereotypes study in urolithiasis patients Anokhin N.A., Prosiannikov M.Y., Shaderkin I.A., Konstantinova O.V., Golovanov S.A., Zelenskiy M.M., Voytko D.A., Apolihin O.I., Sivkov A.V. (Moscow, Russia) 61 Distinguishing of impacted ureteral stones by using Hounsfield units Özbir S., Atalay H.A. (Istanbul, Turkey) 62 Percutaneous nephrolithotomy for staghorn stones Chaker K., Sellami A., Ouanes Y., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia) 63 Evaluation of endoscopic treatment of complicated ureterocele in adults Chaker K., Sellami A., Ouanes Y., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia) 64 Treatment modalities and its impact on the management of Steinstrasse Chaker K., Sellami A., Ben Chehida M.A., Ben Rhouma S., Nouira Y. (Tunis, Tunisia) 65 Endoscopic combined intrarenal surgery value in multiple renal stones treatment Kavaliauskaite R., Želvys A. (Vilnius, Lithuania) 66 A prospective, randomized comparison of retrograde intrarenal surgery and percutaneous nephrolithotomy for treatment of 1 to 2 cm lower calyceal renal stones Bayar G., Kilinc M.F., Yavuz A., Yazar V.M., Cakmak S. (Istanbul,Ankara,Hatay, Turkey) 67 The influence of stone burden and its ratio to renal collecting system volume on complication rates of percutaneous nephrolithotomy Özbir S., Atalay H.A. (Istanbul, Turkey) 68 The effect of perirenal fat stranding on infection related complications after ureterorenoscopy in patients with ureteral calculi Demirelli E., Ögreden E., Bayraktar C., Tosun A., Oguz U. (Giresun, Turkey) 12 5th Baltic meeting in conjunction with the EAU

13 Poster session 5 Saturday, 26 May Urothelial tumours and BPO Chairs: A. Minich, Minsk (BY) TBC Beta Room 1 69 Assessment of haematuria Kannan S., Bhuvanagiri A., Gundupalli D., Fegredo D., Nadeem T., Allen B., Robinson B., Tivey A., Edge E., Thangavelu M., Ahiaku E.K, Alexandrou K. (Bangor, United Kingdom) 70 Gender-related differences in clinicopathological features of patients with upper urinary tract urothelial carcinoma Kaczmarek K., Leminski A., Gajewska D., Gołab A., Soczawa M., Słojewski M. (Szczecin, Poland) 71 Men have an increased incidence of high stage bladder cancer Gajewska D., Kaczmarek K., Poletajew S., Krajewski W., Sondka-Migdalska J., Borowik M., Buraczynski P., Dziegała M., Łykowski M., Przudzik M., Bar K., Jabłonowski Z., Roslan M., Zdrojowy R., Radziszewski P., Słojewski M. (Szczecin, Warsaw, Wrocław,Łódz,Olsztyn,Lublin, Poland) 72 Evaluation of second-look transurethral resection in restaging of patients with T1 high-grade bladder cancer Chaker K., Ben Rhouma S., Sellami A., Ben Chehida M.A., Nouira Y. (Tunis, Tunisia) 73 Prognostic significance of pathological substaging of T1 urothelial transitionalcell carcinoma Nabebina T.I., Rolevich A.I., Mokhort A., Dubrouski A.Ch., Krasny S.A. (Minsk, Belarus) 74 A candidate antineoplastic herbal agent in bladder cancer: Ankaferd the bloodstopper Sari H., Celik S., Aktas S., Bozkurt O., Yorukoglu K., Celebi I., Mungan M.U. (Izmir, Turkey) 75 Pyuria can be prognostic marker for poor oncological outcome prior TUR-BT Gajewska D., Kaczmarek K., Poletajew S., Krajewski W., Sondka-Migdalska J., Borowik M., Buraczynski P., Dziegała M., Łykowski M., Przudzik M., Radziszewski P., Bar K., Jabłonowski Z., Roslan M., Zdrojowy R., Słojewski M. (Szczecin, Warsaw, Wrocław, Łódz, Olsztyn, Lublin, Poland) 76 Correlation between perioperative parameters and long-term survival after radical cystectomy Ryndzin A., Zaitseva L., Poluyanchik A., Minich A., Krasny S. (Minsk district, Lesnoy, Belarus) 77 Analysis of the perioperative and oncological outcome of 164 cases of laparoscopic radical cystectomy: A single center experience Semenov D., Nosov A., Djalilov I., Petrov S., Reva S. (S-Petersburg, Russia) 78 Laparoscopic radical cystectomy in the elderly: Analysis of a single center Semenov D., Nosov A., Djalilov I., Petrov S., Reva S. (S-Petersburg, Russia) 79 A comparison of EORTC and CUETO risk tables in terms of the prediction of recurrence and progression in all non-muscleinvasive bladder cancer patients Dalkilic A., Bayar G., Kilinc M.F. (Istanbul,Ankara, Turkey) 80 Sexual life outcomes after radical cystectomy with external urinary derivation Chaker K., Sellami A., Ouanes Y., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia) 81 Prostate resection speed in TURP - how determining is this for patients and how appropriate as a measure for assessing trainees? Donati-Bourne J.F., Nour S.S., Delves G. (Burton-on-Trent, United Kingdom) 82 The most important factor in prostate biopsy decision of patients with high prostate volume (over 80 cc) is PSA density Ediz C., Yilmaz Ö., Akan S., Temel M.C., Ates F., Cimen S. (Istanbul,Malatya, Turkey) 83 Does the dutasteride has any cardioprotective effect in elderly men? Prospective - randomised - non-placebo controlled study Oguz U., Karagöz A., Tosun A., Demirelli E., Usta M., Ögreden E., Karagöz E., Karadayi M., Köseoglu M.H., Baser B., Yalçın O. (Giresun, Turkey) 84 Comparison of hemostatic methods for transvesical prostatectomy and large prostatic adenoma Adaschik V., Strotsky A., Buldyk Y., Gavrusev A. (Minsk, Belarus) May

14 Poster session 6 Saturday, 26 May Infections and paediatrics Chairs: V. Lietuvietis, Riga (LV) TBC Beta Room 2 85 Retrospective evaluation of patients semen culture with CPPS/CP like symptoms Markevicius M. (Klaipeda, Lithuania) 86 Antibiotic resistance E. coli in urological hospitals Rudenka D., Scobeus I.A., Strotsky A.V., Rahuzin A. (Minsk, Belarus) 87 Antibiotic resistance in patients with complicated urinary tract infections and acute pyelonephritis in Pauls Stradins Clinical University Hospital Pogodina V., Vjaters E. (Riga, Latvia) 88 Outcome and clinical characteristics of urosepsis patients in a tertiary hospital intensive care unit Freimanis A., Laizans S., Silina S., Redmanis L., Lietuvietis V. (Riga, Latvia) 89 Hospital admission following transrectal ultrasound scan and prostate biopsy Bhuvanagiri A.K., Kannan S., William S.M.W., Gundupalli D., Hassan U., Fegredo D., Allen B., Robinson B., Arshad S., Nadeem T., Tivey A., Edge E., Thangavelu M., Ahiaku E.K, Alexandrou K. (Bangor, United Kingdom) 90 Drug resistance of Trichomonas vaginalis in patients with recurrent urethroprostatitis Gavrusev A., Strotsky A., Malashchitsky D., Rubanik L. (Minsk, Belarus) 91 Surgical correction of combined ureteral obstructions in children Youshko E., Strotsky A. (Minsk, Belarus) 92 The relationship between inhalant allergens and nocturnal enuresis: A prospective and controlled trial Yavuz A., Yildirim O., Bayar G., Uslu B., Bayar G., Kilinc M.F. (Hatay,Istanbul,Ankara, Turkey) 93 The relationship between nocturnal enuresis and spina bifida occulta: A prospective controlled trial Yavuz A., Bayar G., Kilinc M.F., Sariogullari U. (Hatay,Istanbul,Ankara, Turkey) 94 Can we predict the need for surgery for a communicating hydrocele in infants: Prospective cohort study Bayar G., Yavuz A., Kilinc M.F., Dalkilic A., Horasanli K. (Istanbul,Hatay,Ankara, Turkey) 14 5th Baltic meeting in conjunction with the EAU

15 Do not miss the Award Session! Prestigious awards for Best Poster Presentations and Young Urologist Competitors will be handed out on the last day of the meeting The awards will be presented at the end of the meeting by Dr. Peteris Vaganovs. The award winners will be selected on-site by the chairmen of the poster sessions. The award-winning posters will be displayed in a specifically designated area at the Annual EAU Congress The award winners will be invited to present their poster at the 34th Annual EAU congress in Barcelona, March 2019 the duration of the congress. Saturday, 26 May hrs Plenary Room (Alfa room) Industry sponsored

16 5th Baltic Meeting in conjunction with the May 2018, Riga, Latvia (Baltic18) Session sponsored by Berlin-Chemie/Menarini Friday, 25 May 2018, ERECTILE DYSFUNCTION AND LUTS Chair: E. Vjaters, Riga (LV) Overactive Bladder, LUTS and Erectile Dysfunction C.R. Chapple, Sheffield (GB) Secrets in the use of PDE5i: Lessons from the everyday clinical practice D. Hatzichristou, Thessaloniki (GR) followed by Case discussion K. Miculis, Riga (LV) and R. Okas, Tallinn (EE) Venue: Radisson Blu Hotel Latvija BC-ID-PRO-1 Elizabetes 55, LV-1010 Riga, Latvia

17 INVITATION Janssen Satellite Symposium at the 5th Baltic Meeting in conjunction with the EAU Treatment landscape of metastatic prostate cancer: are there any changes? Venue Radisson Blu Hotel Latvija 26 th May, :45 10:45 Moderated by Dr. Peteris Vaganovs (LV) Welcome and Introduction Dr. Peteris Vaganovs Treatment landscape of metastatic prostate cancer: are there any changes? Prof. Nicolas Mottet (FR) Discussion, Q&A (All) PHBL/ZYT/0518/0001

18 Contributors The EAU is very grateful for the support of the following contributors: MAIN SPONSORS SPONSORS ASTELLAS BIONORICA BRAUN IPSEN NOVARTIS OLYMPUS PHARMA SWISS SCANMED WOLF 18

19 BALTIC19 6th Baltic Meeting in conjunction with the EAU May 2019, Tallinn, Estonia An application has been made to the EACCME for CME accreditation of this event Call for Abstracts Deadline 1 April 2019

20 Cutting-edge Science at Europe s largest Urology Congress Abstract submission deadline: 1 November th Annual EAU Congress